Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations.

Saved in:
Bibliographic Details
Title: Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations.
Authors: Lin, Anqi1 (AUTHOR), Wei, Ting1 (AUTHOR), Meng, Hui1 (AUTHOR), Luo, Peng1 (AUTHOR) luopeng@smu.edu.cn, Zhang, Jian1 (AUTHOR) blacktiger@139.com
Source: Molecular Cancer. 9/16/2019, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p. 3 Diagrams, 2 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-019-1062-7